Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

GAVISCON DOUBLE ACTION TABLETS

Approval Number

SIN14194P

Drug Name

GAVISCON DOUBLE ACTION TABLETS

Product Name

GAVISCON DOUBLE ACTION TABLETS

Approval Date

July 17, 2012

Registrant

RECKITT BENCKISER (SINGAPORE) PTE LTD

Licence Holder

RECKITT BENCKISER (SINGAPORE) PTE LTD

Regulatory Information

Registrant

RECKITT BENCKISER (SINGAPORE) PTE LTD

Licence Holder

RECKITT BENCKISER (SINGAPORE) PTE LTD

Drug Type

Therapeutic

Forensic Classification

General Sale List

Formulation Information

Dosage Form

TABLET, CHEWABLE

Route of Administration

ORAL

Medical Information

ATC Code

A02BX13

ATC Item Name

alginic acid

Manufacturer Information

Pharmaceutical Manufacturer

RECKITT BENCKISER (SINGAPORE) PTE LTD

Manufacturers

RECKITT BENCKISER HEALTHCARE (UK) LIMITED

Active Ingredients

Ingredient Name

CALCIUM CARBONATE

Strength

187.5MG

Drug MonographCalcium carbonate

Ingredient Name

SODIUM BICARBONATE

Strength

106.5MG

Drug MonographSodium bicarbonate

Ingredient Name

SODIUM ALGINATE

Strength

250MG

Drug MonographAlginic acid

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy